Market Overview:
The global tuberculosis diagnostic market is expected to grow at a CAGR of 6.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of tuberculosis, growing awareness about tuberculosis diagnosis and rising demand for rapid and accurate diagnosis methods. Based on type, the global tuberculosis diagnostic market is segmented into radiographic method, diagnostic laboratory methods, nucleic acid testing, phage assay, detection of latent infection, cytokine detection assay and detection of drug resistance. The radiographic method segment is expected to dominate the global tuberculosis diagnostic market in 2018 owing to its high accuracy and widespread use for diagnosing pulmonary TB cases. However, the nucleic acid testing segment is projected to grow at a highest CAGR during the forecast period due to its ability detect both active and latent TB infections accurately.
Product Definition:
A diagnostic test used to determine if a person has tuberculosis (TB) is the tuberculin skin test. The tuberculin skin test is also called the Mantoux skin test.
Radiographic Method:
Radiographic method is a diagnostic procedure that uses x-rays, computed tomography (CT), or magnetic resonance imaging (MRI) to identify tuberculosis. Tuberculosis is an infectious disease of the lungs and chest cavity caused by mycobacterium TB. The most common symptoms associated with it are cough, night sweat, blood-tinged sputum, and fever. According to the Centers for Disease Control & Prevention (CDC), 1 million people in U.
Diagnostic Laboratory Methods:
The global diagnostic laboratory methods and its usage in tuberculosis diagnostic market is analyzed by considering the unmet medical needs, existing product portfolios, technological advancements, competitive landscape and future forecasts. The study aims at providing an overall perspective of the industry for diagnostics related to tuberculosis.
Application Insights:
Based on application, the market is segmented into infants, children and adults. The children and adult segment held the largest share in 2017 due to increase in prevalence of tuberculosis among this population. According to WHO, 1TB of tuberculosis disease burden falls on children below 15 years of age which indicates a huge potential market for diagnostics in this segment.
The infant segment is expected to be one of the fastest growing segments during forecast period owing to rise in number of TB cases among infants globally including India China Brazil Russia South Africa Australia New Zealand U.S Mexico Chile Colombia Germany France Italy Japan Russia China Brazil Japan France Germany Argentina Canada Mexico South Africa U.
Regional Analysis:
Asia Pacific is estimated to be the fastest growing region during the forecast period. The high prevalence of MDR and XDR tuberculosis, increasing number of HIV-positive patients with active TB, rising healthcare expenditure, and improving economic conditions in countries such as India are some of the major factors contributing towards regional growth. In addition, government initiatives for mass drug administration (MDA) are also expected to boost market development over the forecast period. For instance; in November 2016; Ministry Of Health & Family Welfare Government Of India launched a nation-wide MDA initiative covering 90% population under treatment by 2020.
In Latin America, Brazil accounted for a revenue share of more than 25% in 2017 owing to its large population base suffering from multidrug resistant tuberculosis (MDRTB). Moreover; Argentina has also been witnessing an increase in incidence rates due to continuous immigration from countries such as India & China where there is high prevalence of infectious diseases including TB.
Growth Factors:
- Increasing incidence of tuberculosis (TB) across the globe
- Rising demand for rapid and accurate TB diagnosis tests
- Growing number of public-private partnerships for TB diagnosis research and development
- Proliferation of point-of-care TB diagnostic tests
- Technological advancements in TB diagnostics
Scope Of The Report
Report Attributes
Report Details
Report Title
Tuberculosis Diagnostic Market Research Report
By Type
Radiographic Method, Diagnostic Laboratory Methods, Nucleic Acid Testing, Phage Assay, Detection of Latent Infection, Cytokine Detection Assay, Detection of Drug Resistance
By Application
Infants, Adults
By Companies
Thermo Fisher Scientific, Hologic Corporation, Abbott, Becton Dickinson, Roche, bioMerieux, Sanofi, Cepheid, Hain Lifescience, QIAGEN
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
215
Number of Tables & Figures
151
Customization Available
Yes, the report can be customized as per your need.
Global Tuberculosis Diagnostic Market Report Segments:
The global Tuberculosis Diagnostic market is segmented on the basis of:
Types
Radiographic Method, Diagnostic Laboratory Methods, Nucleic Acid Testing, Phage Assay, Detection of Latent Infection, Cytokine Detection Assay, Detection of Drug Resistance
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Infants, Adults
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thermo Fisher Scientific
- Hologic Corporation
- Abbott
- Becton Dickinson
- Roche
- bioMerieux
- Sanofi
- Cepheid
- Hain Lifescience
- QIAGEN
Highlights of The Tuberculosis Diagnostic Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Radiographic Method
- Diagnostic Laboratory Methods
- Nucleic Acid Testing
- Phage Assay
- Detection of Latent Infection
- Cytokine Detection Assay
- Detection of Drug Resistance
- By Application:
- Infants
- Adults
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Tuberculosis Diagnostic Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A tuberculosis diagnostic test is a medical procedure used to determine if someone has tuberculosis. The test uses a sample of the person's blood or sputum to look for signs of the disease.
Some of the key players operating in the tuberculosis diagnostic market are Thermo Fisher Scientific, Hologic Corporation, Abbott, Becton Dickinson, Roche, bioMerieux, Sanofi, Cepheid, Hain Lifescience, QIAGEN.
The tuberculosis diagnostic market is expected to register a CAGR of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Tuberculosis Diagnostic Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Tuberculosis Diagnostic Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Tuberculosis Diagnostic Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Tuberculosis Diagnostic Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Tuberculosis Diagnostic Market Size & Forecast, 2018-2028
4.5.1 Tuberculosis Diagnostic Market Size and Y-o-Y Growth
4.5.2 Tuberculosis Diagnostic Market Absolute $ Opportunity
Chapter 5 Global Tuberculosis Diagnostic Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Tuberculosis Diagnostic Market Size Forecast by Type
5.2.1 Radiographic Method
5.2.2 Diagnostic Laboratory Methods
5.2.3 Nucleic Acid Testing
5.2.4 Phage Assay
5.2.5 Detection of Latent Infection
5.2.6 Cytokine Detection Assay
5.2.7 Detection of Drug Resistance
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Tuberculosis Diagnostic Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Tuberculosis Diagnostic Market Size Forecast by Applications
6.2.1 Infants
6.2.2 Adults
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Tuberculosis Diagnostic Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Tuberculosis Diagnostic Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Tuberculosis Diagnostic Analysis and Forecast
9.1 Introduction
9.2 North America Tuberculosis Diagnostic Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Tuberculosis Diagnostic Market Size Forecast by Type
9.6.1 Radiographic Method
9.6.2 Diagnostic Laboratory Methods
9.6.3 Nucleic Acid Testing
9.6.4 Phage Assay
9.6.5 Detection of Latent Infection
9.6.6 Cytokine Detection Assay
9.6.7 Detection of Drug Resistance
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Tuberculosis Diagnostic Market Size Forecast by Applications
9.10.1 Infants
9.10.2 Adults
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Tuberculosis Diagnostic Analysis and Forecast
10.1 Introduction
10.2 Europe Tuberculosis Diagnostic Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Tuberculosis Diagnostic Market Size Forecast by Type
10.6.1 Radiographic Method
10.6.2 Diagnostic Laboratory Methods
10.6.3 Nucleic Acid Testing
10.6.4 Phage Assay
10.6.5 Detection of Latent Infection
10.6.6 Cytokine Detection Assay
10.6.7 Detection of Drug Resistance
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Tuberculosis Diagnostic Market Size Forecast by Applications
10.10.1 Infants
10.10.2 Adults
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Tuberculosis Diagnostic Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Tuberculosis Diagnostic Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Tuberculosis Diagnostic Market Size Forecast by Type
11.6.1 Radiographic Method
11.6.2 Diagnostic Laboratory Methods
11.6.3 Nucleic Acid Testing
11.6.4 Phage Assay
11.6.5 Detection of Latent Infection
11.6.6 Cytokine Detection Assay
11.6.7 Detection of Drug Resistance
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Tuberculosis Diagnostic Market Size Forecast by Applications
11.10.1 Infants
11.10.2 Adults
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Tuberculosis Diagnostic Analysis and Forecast
12.1 Introduction
12.2 Latin America Tuberculosis Diagnostic Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Tuberculosis Diagnostic Market Size Forecast by Type
12.6.1 Radiographic Method
12.6.2 Diagnostic Laboratory Methods
12.6.3 Nucleic Acid Testing
12.6.4 Phage Assay
12.6.5 Detection of Latent Infection
12.6.6 Cytokine Detection Assay
12.6.7 Detection of Drug Resistance
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Tuberculosis Diagnostic Market Size Forecast by Applications
12.10.1 Infants
12.10.2 Adults
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Tuberculosis Diagnostic Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Tuberculosis Diagnostic Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Tuberculosis Diagnostic Market Size Forecast by Type
13.6.1 Radiographic Method
13.6.2 Diagnostic Laboratory Methods
13.6.3 Nucleic Acid Testing
13.6.4 Phage Assay
13.6.5 Detection of Latent Infection
13.6.6 Cytokine Detection Assay
13.6.7 Detection of Drug Resistance
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Tuberculosis Diagnostic Market Size Forecast by Applications
13.10.1 Infants
13.10.2 Adults
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Tuberculosis Diagnostic Market: Competitive Dashboard
14.2 Global Tuberculosis Diagnostic Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Thermo Fisher Scientific
14.3.2 Hologic Corporation
14.3.3 Abbott
14.3.4 Becton Dickinson
14.3.5 Roche
14.3.6 bioMerieux
14.3.7 Sanofi
14.3.8 Cepheid
14.3.9 Hain Lifescience
14.3.10 QIAGEN
